VDR and non-small cell lung carcinoma: In the genotypic model, patients carrying the VDR BsmI rs1544410-AA genotype had a lower risk of NSCLC relative to the GG genotype (pBonferroni-adjusted = 0.0361; OR = 0.457; CI95% = 0.26–0.76; AA vs. GG).